Evidence map›Paper›PMID 42752827›Full record

ArticlePhysical and engineering sciences in medicine2026

ACPSEM guideline regarding the adoption of the IAEA TRS-398 Code of Practice Revision 1.

Joerg Lehmann, Jeffrey Barber, Andrew Alves, Simon Berke, Rhonda Brown, Peter Harty, Brendan Healy, Robin Hill, Stewart Midgley, Vaughan Moutrie and 8 more

Abstract read
PubMed Publisher
In one paragraph

Article in Physical and engineering sciences in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Joerg LehmannInstitute of Medical Physics, University of Sydney, Sydney, NSW, Australia. Joerg.Lehmann@sydney.edu.au.ORCID http://orcid.org/0000-0001-7667-3090
Jeffrey BarberInstitute of Medical Physics, University of Sydney, Sydney, NSW, Australia.ORCID http://orcid.org/0000-0003-0233-0970
Andrew AlvesAustralian Radiation Protection and Nuclear Safety Agency, Yallambie, VIC, Australia.ORCID http://orcid.org/0000-0001-9385-1274
Simon BerkeCapital Coast and Hutt Valley, Blood and Cancer Centre, Health New Zealand - Te Whatu Ora, Wellington, New Zealand.
Rhonda BrownAustralian Radiation Protection and Nuclear Safety Agency, Yallambie, VIC, Australia.ORCID http://orcid.org/0000-0003-2375-297X
Peter HartyAustralian Radiation Protection and Nuclear Safety Agency, Yallambie, VIC, Australia.
Brendan HealyAustralian Radiation Protection and Nuclear Safety Agency, Yallambie, VIC, Australia.ORCID http://orcid.org/0000-0001-5914-674X
Robin HillInstitute of Medical Physics, University of Sydney, Sydney, NSW, Australia.ORCID http://orcid.org/0000-0002-6889-7323
Stewart MidgleyMedical Imaging, Western Health, Gordon Street, Footscray, VIC, Australia.ORCID http://orcid.org/0000-0001-5355-1904
Vaughan MoutrieSouth Western Sydney Cancer Services, Sydney, Australia.ORCID http://orcid.org/0000-0001-8332-8041
Chris OliverAustralian Radiation Protection and Nuclear Safety Agency, Yallambie, VIC, Australia.ORCID http://orcid.org/0009-0001-3799-5211
Scott PenfoldAustralian Bragg Centre for Proton Therapy and Research, Adelaide, SA, Australia.ORCID http://orcid.org/0000-0002-3422-9108
Alison ScottSir Charles Gairdner Hospital, Nedlands, WA, Australia.ORCID http://orcid.org/0000-0001-7741-4680
Allan StewartAuckland City Hospital, Auckland, New Zealand.
Brindha SubramanianGenesisCare Victoria, Auckland City Hospital, Ringwood East, VIC, Australia.
Daniel TruantInstitute of Medical Physics, University of Sydney, Sydney, NSW, Australia.
Madelaine TylerShoalhaven Cancer Care Centre, Nowra, NSW, Australia.ORCID http://orcid.org/0009-0006-1598-0381
Duncan ButlerAustralian Radiation Protection and Nuclear Safety Agency, Yallambie, VIC, Australia.ORCID http://orcid.org/0000-0001-8634-2391

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The IAEA Technical Report Series 398 Code of Practice for the determination of absorbed dose in external beam radiotherapy was endorsed at the Engineers and Physical Scientists in Medicine (EPSM) conference in 2001 and has been widely adopted in Australia and New Zealand. This guideline provides recommendations from the Australasian College of Physical Scientists and Engineers in Medicine (ACPSEM) following the recent publication of TRS-398 Revision 1. It is jointly authored by the Australian Radiation Protection and Nuclear Safety Agency (ARPANSA), the Reference Dosimetry Advisory Group (RDAG) and the ACPSEM Radiation Oncology Specialty Group (ROSG). In addition to recommendations, the guideline discusses the implications of TRS-398 Revision 1 for the dosimetry of megavoltage photons, electrons and protons. TRS-398 Revision 1 is recommended for adoption in accordance with the recommendations provided in this guideline, including for FFF beams. For specialised FFF machines such as CyberKnife

Indexed as

ACPSEM, guideline, megavoltage photon dosimetrymegavoltage electron dosimetryTRS-398 Revision 1

Identifiers

PMID42752827

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.